These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32728827)

  • 1. A multiphase model of growth factor-regulated atherosclerotic cap formation.
    Watson MG; Byrne HM; Macaskill C; Myerscough MR
    J Math Biol; 2020 Aug; 81(2):725-767. PubMed ID: 32728827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-phase model of early fibrous cap formation in atherosclerosis.
    Watson MG; Byrne HM; Macaskill C; Myerscough MR
    J Theor Biol; 2018 Nov; 456():123-136. PubMed ID: 30098319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.
    Sukhanov S; Higashi Y; Shai SY; Snarski P; Danchuk S; D'Ambra V; Tabony M; Woods TC; Hou X; Li Z; Ozoe A; Chandrasekar B; Takahashi SI; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2306-2317. PubMed ID: 30354209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smooth muscle cell-specific deletion of
    Durgin BG; Cherepanova OA; Gomez D; Karaoli T; Alencar GF; Butcher JT; Zhou YQ; Bendeck MP; Isakson BE; Owens GK; Connelly JJ
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H943-H958. PubMed ID: 28283548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discoidin Domain Receptor-1 Regulates Calcific Extracellular Vesicle Release in Vascular Smooth Muscle Cell Fibrocalcific Response via Transforming Growth Factor-β Signaling.
    Krohn JB; Hutcheson JD; Martínez-Martínez E; Irvin WS; Bouten CV; Bertazzo S; Bendeck MP; Aikawa E
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):525-33. PubMed ID: 26800565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells--a potential mechanism for the weakening and rupture of atherosclerotic plaques.
    Leskinen MJ; Kovanen PT; Lindstedt KA
    Biochem Pharmacol; 2003 Oct; 66(8):1493-8. PubMed ID: 14555226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin beta3 regulates clonality and fate of smooth muscle-derived atherosclerotic plaque cells.
    Misra A; Feng Z; Chandran RR; Kabir I; Rotllan N; Aryal B; Sheikh AQ; Ding L; Qin L; Fernández-Hernando C; Tellides G; Greif DM
    Nat Commun; 2018 May; 9(1):2073. PubMed ID: 29802249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the transforming growth factor-beta signaling pathway, endoglin, and early growth response-1 in stable plaques.
    Bot PT; Hoefer IE; Sluijter JP; van Vliet P; Smits AM; Lebrin F; Moll F; de Vries JP; Doevendans P; Piek JJ; Pasterkamp G; Goumans MJ
    Stroke; 2009 Feb; 40(2):439-47. PubMed ID: 19074480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse cellular architecture of atherosclerotic plaque derives from clonal expansion of a few medial SMCs.
    Jacobsen K; Lund MB; Shim J; Gunnersen S; Füchtbauer EM; Kjolby M; Carramolino L; Bentzon JF
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
    Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
    Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
    Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
    Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone inhibits connective tissue growth factor expression in advanced atherosclerotic plaques in low-density lipoprotein receptor-deficient mice.
    Game BA; He L; Jarido V; Nareika A; Jaffa AA; Lopes-Virella MF; Huang Y
    Atherosclerosis; 2007 May; 192(1):85-91. PubMed ID: 16901490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway.
    Gisterå A; Robertson AK; Andersson J; Ketelhuth DF; Ovchinnikova O; Nilsson SK; Lundberg AM; Li MO; Flavell RA; Hansson GK
    Sci Transl Med; 2013 Jul; 5(196):196ra100. PubMed ID: 23903754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration.
    Zhou B; Zu L; Chen Y; Zheng X; Wang Y; Pan B; Dong M; Zhou E; Zhao M; Zhang Y; Zheng L; Gao W
    Lipids Health Dis; 2017 Jan; 16(1):3. PubMed ID: 28069011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PM2.5 promotes plaque vulnerability at different stages of atherosclerosis and the formation of foam cells via TLR4/MyD88/NFκB pathway.
    Geng J; Liu H; Ge P; Hu T; Zhang Y; Zhang X; Xu B; Wang B; Xie J
    Ecotoxicol Environ Saf; 2019 Jul; 176():76-84. PubMed ID: 30921699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New information on the pathophysiology of atherosclerosis].
    Reiner Z; Tedeschi-Reiner E
    Lijec Vjesn; 2001; 123(1-2):26-31. PubMed ID: 11379194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.
    Cai Y; Nagel DJ; Zhou Q; Cygnar KD; Zhao H; Li F; Pi X; Knight PA; Yan C
    Circ Res; 2015 Mar; 116(7):1120-32. PubMed ID: 25608528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell chymase inhibits smooth muscle cell growth and collagen expression in vitro: transforming growth factor-beta1-dependent and -independent effects.
    Wang Y; Shiota N; Leskinen MJ; Lindstedt KA; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1928-33. PubMed ID: 11742866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis.
    Jean-Charles PY; Wu JH; Zhang L; Kaur S; Nepliouev I; Stiber JA; Brian L; Qi R; Wertman V; Shenoy SK; Freedman NJ
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2295-2305. PubMed ID: 30354204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smooth muscle cell fate and plasticity in atherosclerosis.
    Allahverdian S; Chaabane C; Boukais K; Francis GA; Bochaton-Piallat ML
    Cardiovasc Res; 2018 Mar; 114(4):540-550. PubMed ID: 29385543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.